Latest News

Drugging the catalytically inactive state of RET kinase in RET-rearranged tumors




Plenker, D; Riedel, M; Braegelmann, J; Dammert, MA; Chauhan, R; Knowles, PP; Lorenz, C; … Sos, ML; + view all Plenker, D; Riedel, M; Braegelmann, J; Dammert, MA; Chauhan, R; Knowles, PP; Lorenz, C; Keul, M; Buehrmann, M; Pagel, O; Tischler, V; Scheel, AH; Schtte, D; Song, Y; Stark, J; Mrugalla, F; Alber, Y; Richters, A; Engel, J; Leenders, F; Heuckmann, JM; Wolf, J; Diebold, J; Pall, G; Peifer, M; Aerts, M; Gevaert, K; Zahedi, RP; Buettner, R; Shokat, KM; McDonald, NQ; Kast, SM; Gautschi, O; Thomas, RK; Sos, ML; – view fewer (2017) Drugging the catalytically inactive state of RET kinase in RET-rearranged tumors. Science Translational Medicine , 9 (394) , Article eaah6144. 10.1126/scitranslmed.aah6144 . Green open access

Source link





Related posts

STAT Plus: Kentucky probes pharmacy benefit managers for allegedly overcharging state Medicaid

Newsemia

Economy of Effort or Maximum Rate of Information? Exploring Basic Principles of Articulatory Dynamics

Newsemia

What does supportive care mean for patients with COVID-19?

Newsemia

This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish. Accept Read More

Privacy & Cookies Policy